The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells
Open accessAbstract
Alpha-synuclein (ASYN) is crucial in Parkinson disease (PD) pathogenesis. Increased levels of wild type (WT) ASYN expression are sufficient to cause PD in humans. The manner of post-transcriptional regulation of ASYN levels is controversial. Previously, we had shown that WT ASYN can be degraded by chaperone-mediated autophagy (CMA) in isolated liver lysosomes. Whether this occurs in a cellular and, in particular, in a neuronal cell context is unclear. Using a mutant ASYN form that lacks the CMA recognition motif and RNA interference against the rate-limiting step in the CMA pathway, Lamp2a, we show here that CMA is indeed involved in WT ASYN degradation in PC12 and SH-SY5Y cells, and in primary cortical and midbrain neurons. However, the extent of involvement varies between cell types, potentially because of differences in compensatory mechanisms. CMA inhibition leads to an accumulation of soluble high molecular weight and detergent-insoluble species of ASYN, suggesting that CMA dysfunction may play a role in the generation of such aberrant species in PD. ASYN and Lamp2a are developmentally regulated in parallel in cortical neuron cultures and in vivo in the central nervous system, and they physically interact as indicated by co-immunoprecipitation. In contrast to previous reports, inhibition of macroautophagy, but not the proteasome, also leads to WT ASYN accumulation, suggesting that this lysosomal pathway is also involved in normal ASYN turnover. These results indicate that CMA and macroautophagy are important pathways for WT ASYN degradation in neurons and underline the importance of CMA as degradation machinery in the nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies suggest that α-synuclein is degraded by macroautophagy, chaperone-mediated autophagy, and the proteasome20–23.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [22]
In the citing paper
“dopamine-modified α-synuclein blocks chaperone-mediated autophagy [109,110], which induces abnormal intracellular accumulation α-synuclein in PD [120].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Autophagy in Health and Disease: A Double-Edged Sword
Shintani, T., & Klionsky, D. J. (2004) · Science · doi:10.1126/science.1099993 · Cited by 2,559
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Self-citationRubinson, D. A., Dillon, C. P., Kwiatkowski, A. V., Sievers, C., Yang, L., Kopinja, J. E., Rooney, D. L., Zhang, M., Ihrig, M. M., McManus, M. T., et al. (2003) · Nature Genetics · doi:10.1038/ng1117 · Cited by 1,499
Flagged first, then by citations
Research works printed but not linked: 1
- Martinez-Vicente, 2008, J. Clin. Investig., 118, 777
Cited by
Sorted by citations
Items 101–200 of 683
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Senkevich, K. A., & Gan‐Or, Z. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.015 · Cited by 138
Brás, J., Singleton, A., Cookson, M., & Hardy, J. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06709.x · Cited by 133
Machiya, Y., Hara, S., Arawaka, S., Fukushima, S., Sato, H., Sakamoto, M., Koyama, S., & Kato, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141952 · Cited by 137
α-Synuclein and Neuronal Cell Death
Yasuda, T., Nakata, Y., & Mochizuki, H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8327-0 · Cited by 131
Su, L., Li, H., Lv, L., Feng, Y., Li, G., Luo, R., Zhou, H., Lei, X., Ma, L., Li, J., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1082020 · Cited by 128
Autophagy deregulation in neurodegenerative diseases – recent advances and future perspectives
Cheung, Z. H., & Ip, N. Y. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07314.x · Cited by 131
Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats
Xilouri, M., Brekk, O. R., Polissidis, A., Chrysanthou‐Piterou, M., Kloukina, I., & Stefanis, L. (2016) · Autophagy · doi:10.1080/15548627.2016.1214777 · Cited by 126
Self-citationFunctional Protein Delivery into Neurons Using Polymeric Nanoparticles
Hasadsri, L., Kreuter, J., Hattori, H., Iwasaki, T., & George, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805956200 · Cited by 129
Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calí, T., Gai, W., Chen, T., et al. (2018) · EMBO Reports · doi:10.15252/embr.201744617 · Cited by 127
Liu, H., Wang, P., Song, W., & Sun, X. (2009) · The FASEB Journal · doi:10.1096/fj.09-134296 · Cited by 124
Regional differences in the severity of Lewy body pathology across the olfactory cortex
Silveira‐Moriyama, L., Holton, J. L., Kingsbury, A. E., Ayling, H., Petrie, A., Sterlacci, W., Poewe, W. H., Maier, H., Lees, A. J., & Révész, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.006 · Cited by 123
The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
Dulović, M., Jovanović, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L. M., Kravic‐Stevovic, T., Paunović, V., Ardah, M. T., El‐Agnaf, O. M. A., Kostić, V., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.002 · Cited by 124
Self-citationLAMP3 inhibits autophagy and contributes to cell death by lysosomal membrane permeabilization
Tanaka, T., Warner, B. M., Michael, D. G., Nakamura, H., Odani, T., Yin, H., Atsumi, T., Noguchi, M., & Chiorini, J. A. (2021) · Autophagy · doi:10.1080/15548627.2021.1995150 · Cited by 123
Konno, M., Hasegawa, T., Baba, T., Miura, E., Sugeno, N., Kikuchi, A., Fiesel, F. C., Sasaki, T., Aoki, M., Itoyama, Y., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-38 · Cited by 122
Park, J., Mehta, P. M., Cooper, A. A., Veivers, D., Heimbach, A., Stiller, B., Kubisch, C., Fung, V. S. C., Krainc, D., Mackay‐Sim, A., et al. (2011) · Human Mutation · doi:10.1002/humu.21527 · Cited by 119
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation
Fishbein, I., Kuo, Y., Giasson, B. I., & Nussbaum, R. L. (2014) · Brain · doi:10.1093/brain/awu291 · Cited by 119
Gao, J., Perera, G., Bhadbhade, M., Halliday, G. M., & Dzamko, N. L. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008733 · Cited by 119
The Vicious Cycle Between α ‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
Bellomo, G., Paciotti, S., Gatticchi, L., & Parnetti, L. (2019) · Movement Disorders · doi:10.1002/mds.27895 · Cited by 116
The role of autophagy in Parkinson's disease: rotenone-based modeling
Xiong, N., Xiong, J., Jia, M., Liu, L., Zhang, X., Chen, Z., Huang, J., Zhang, Z., Hou, L., Luo, Z., et al. (2013) · Behavioral and Brain Functions · doi:10.1186/1744-9081-9-13 · Cited by 117
Molecular mechanisms of α-synuclein and GBA1 in Parkinson’s disease
Stojkovska, I., Krainc, D., & Mazzulli, J. R. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2704-y · Cited by 116
The Interplay between Alpha-Synuclein Clearance and Spreading
da Fonseca, T. L., Villar‐Piqué, A., & Outeiro, T. F. (2015) · Biomolecules · doi:10.3390/biom5020435 · Cited by 115
Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation
Martínez‐Vicente, M. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.03.005 · Cited by 114
The Proteasome Inhibition Model of Parkinson’s Disease
Bentea, E., Verbruggen, L., & Massie, A. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160921 · Cited by 116
Role of Autophagy in Parkinson’s Disease
Cerri, S., & Blandini, F. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180226094351 · Cited by 107
Glutamate, excitotoxicity, and programmed cell death in parkinson disease
Caudle, W. M., & Zhang, J. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.027 · Cited by 107
Rotenone impairs autophagic flux and lysosomal functions in Parkinson’s disease
Wu, F., Xu, H., Guan, J.-J., Hou, Y., Gu, J., Zhen, X., & Qin, Z. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.004 · Cited by 112
Michalska, P., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080740 · Cited by 119
Role of Microtubules in Extracellular Release of Poliovirus
Taylor, M. P., Burgon, T. B., Kirkegaard, K., & Jackson, W. T. (2009) · Journal of Virology · doi:10.1128/jvi.01819-08 · Cited by 106
Xu, J., Xilouri, M., Bruban, J., Shioi, J., Shao, Z., Papazoglou, I., Vekrellis, K., & Robakis, N. K. R. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.017 · Cited by 109
Self-citationPerfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 109
Deng, Y., Shi, J., Liu, J., & Qu, Q. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.04.005 · Cited by 105
Dysregulation of autophagy and mitochondrial function in Parkinson’s disease
Wang, B., Abraham, N. A., Gao, G., & Yang, Q. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0065-1 · Cited by 112
Controlling the mass action of α‐synuclein in Parkinson’s disease
Kim, C., & Lee, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05612.x · Cited by 108
Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity
Zhang, Z., Miah, M. R., Culbreth, M. E., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1844-x · Cited by 101
Synucleinopathies: Where we are and where we need to go
Brás, I. C., Dominguez‐Meijide, A., Gerhardt, E., Koss, D. J., Lázaro, D. F., Santos, P. I., Vasili, E., Xylaki, M., & Outeiro, T. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14965 · Cited by 106
Chaperone‐mediated autophagy: Molecular mechanisms, biological functions, and diseases
Yao, R., & Shen, J. (2023) · MedComm · doi:10.1002/mco2.347 · Cited by 111
Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology
Tyson, T., Steiner, J. A., & Brundin, P. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13449 · Cited by 110
Autophagy in neuronal cells: general principles and physiological and pathological functions
Daμμe, M., Suntio, T., Säftig, P., & Eskelinen, E. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1361-4 · Cited by 109
Vekrellis, K., Xilouri, M., Emmanouilidou, E., & Stefanis, L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06054.x · Cited by 101
Self-citationKett, L. R., Stiller, B., Bernath, M. M., Tasset, I., Blesa, J., Jackson-Lewis, V. R., Chan, R., Zhou, B., Paolo, G. D., Przedborski, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0632-14.2015 · Cited by 103
Navarro-Romero, A., Fernández-González, I., Riera, J., Montpeyó, M., Albert-Bayo, M., López‐Royo, T., Castillo-Sanchez, P., Carnicer-Cáceres, C., Arranz, J. A., Castillo‐Ribelles, L., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00397-6 · Cited by 102
p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
Watanabe, Y., Tatebe, H., Taguchi, K., Endo, Y., Tokuda, T., Mizuno, T., Nakagawa, M., & Tanaka, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052868 · Cited by 104
Wu, H., Chen, S., Al-Baadani, A., Xu, J., Wu, Q., Pan, K., Zhang, J., & Hong, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8933-0 · Cited by 103
Jiang, P., Gan, M., Ebrahim, A. S., Castanedes‐Casey, M., Dickson, D. W., & Yen, S.-H. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.001 · Cited by 99
Autophagic pathways in Parkinson disease and related disorders
Xilouri, M., & Stefanis, L. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001803 · Cited by 100
Self-citationChang, C., Huang, H., Lee, H., Hung, K.-C., Wu, R.-T., & Lin, A. M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00945.x · Cited by 99
Chaperone Mediated Autophagy in the Crosstalk of Neurodegenerative Diseases and Metabolic Disorders
Alfaro, I. E., Albornoz, A., Molina, A., Moreno, J., Cordero, K., Criollo, A., & Budini, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00778 · Cited by 105
Wu, J., Han, Y., Xu, H., Sun, H., Wang, R., Ren, H., & Wang, G. (2023) · Science Advances · doi:10.1126/sciadv.adi8343 · Cited by 109
Key genes and convergent pathogenic mechanisms in Parkinson disease
Coukos, R., & Krainc, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00812-2 · Cited by 116
Suzuki, M., Fujikake, N., Takeuchi, T., Kohyama‐Koganeya, A., Nakajima, K., Hirabayashi, Y., Wada, K., & Nagai, Y. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv372 · Cited by 98
Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion
Tang, Q., Gao, P., Arzberger, T., Höllerhage, M., Herms, J., Höglinger, G., & Koeglsperger, T. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04138-0 · Cited by 103
Chaperone-mediated autophagy dysfunction in the pathogenesis of neurodegeneration
Koga, H., & Cuervo, A. M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.006 · Cited by 98
Import and Export of Misfolded α-Synuclein
Rodriguez, L., Marano, M. M., & Tandon, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00344 · Cited by 93
Genes associated with Parkinson's disease: regulation of autophagy and beyond
Beilina, A. G., & Cookson, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13266 · Cited by 98
Removing Protein Aggregates: The Role of Proteolysis in Neurodegeneration
Nijholt, D. A. T., Kimpe, L. D., Elfrink, H. L., Hoozemans, J. J. M., & Scheper, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843236 · Cited by 96
Rout, A. K., Strub, M., Piszczek, G., & Tjandra, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609446 · Cited by 102
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Sjödin, S., Brinkmalm, G., Öhrfelt, A., Parnetti, L., Paciotti, S., Hansson, O., Hardy, J., Blennow, K., Zetterberg, H., & Brinkmalm, A. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0533-9 · Cited by 94
Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
Esteves, A. R., Arduíno, D. M., Silva, D. F., Oliveira, C. R., & Cardoso, S. M. (2011) · Parkinson s Disease · doi:10.4061/2011/693761 · Cited by 90
α-Synuclein binds the KATP channel at insulin-secretory granules and inhibits insulin secretion
Geng, X., Lou, H., Wang, J., Li, L., Swanson, A., Sun, M., Beers-Stolz, D., Watkins, S. C., Perez, R. G., & Drain, P. F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2010 · Cited by 90
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models
Huarcaya, S. P., Drobny, A., Marques, A. R. A., Spiezio, A. D., Dobert, J. P., Balta, D., Werner, C. D., Rizo, T., Gallwitz, L., Bub, S., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2045534 · Cited by 93
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Yi, S., Wang, L., Wang, H., Ho, M. S.-C., & Zhang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314753 · Cited by 96
The emerging role of autophagy in Parkinson's disease
Cheung, Z. H., & Ip, N. Y. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-29 · Cited by 92
17-AAG Induces Cytoplasmic α-Synuclein Aggregate Clearance by Induction of Autophagy
Riedel, M., Goldbaum, O., Schwarz, L., Schmitt, S., & Richter-Landsberg, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008753 · Cited by 87
Ebrahimi‐Fakhari, D., Saidi, L.-J., & Wahlster, L. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-79 · Cited by 89
Wang, S.-F., Wu, M.-Y., Cai, C.-Z., Li, M., & Lu, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.069 · Cited by 88
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
O’Hara, D. M., Pawar, G. N., Kalia, S. K., & Kalia, L. V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00577 · Cited by 89
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Wales, P., Pinho, R., Lázaro, D. F., & Outeiro, T. F. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130216 · Cited by 89
Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
Limanaqi, F., Biagioni, F., Busceti, C. L., Ryskalin, L., Polzella, M., Frati, A., & Fornai, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133274 · Cited by 87
The beneficial role of autophagy in multiple sclerosis: Yes or No?
Al-Kuraishy, H. M., Jabir, M. S., Al-Gareeb, A. I., Saad, H. M., Batiha, G. E., & Klionsky, D. J. (2023) · Autophagy · doi:10.1080/15548627.2023.2259281 · Cited by 89
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease
Büeler, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0465-0 · Cited by 87
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Arotçarena, M.-L., Teil, M., & Dehay, B. (2019) · Cells · doi:10.3390/cells8060565 · Cited by 91
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
Arotcarena, M.-L., Bourdenx, M., Dutheil, N., Thiolat, M.-L., Doudnikoff, E., Dovero, S., Ballabio, A., Fernagut, P.-O., Meissner, W. G., Bezard, E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129719 · Cited by 84
Petroi, D., Popova, B., Taheri-Talesh, N., Irniger, S., Shahpasandzadeh, H., Zweckstetter, M., Outeiro, T. F., & Braus, G. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.361865 · Cited by 81
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 87
Sun, S., Han, X., Li, X., Song, Q., Lu, M., Jia, M., Ding, J., & Hu, G. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00381 · Cited by 77
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 89
A Critical Review of Zebrafish Models of Parkinson’s Disease
Doyle, J. M., & Croll, R. P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.835827 · Cited by 94
Zhu, G., Wang, X., Wu, S.-B., Li, X., & Li, Q. (2013) · Phytotherapy Research · doi:10.1002/ptr.4975 · Cited by 83
Autophagy, lithium, and amyotrophic lateral sclerosis
Pasquali, L., Longone, P., Isidoro, C., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2009) · Muscle & Nerve · doi:10.1002/mus.21423 · Cited by 84
Arduíno, D. M., Esteves, A. R., Cortes, L., Silva, D. F., Patel, B., Grazina, M. M., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds309 · Cited by 87
Allnutt, A., Waters, A. K., Kesari, S., & Yenugonda, V. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00096 · Cited by 86
The Role of Chaperone-Mediated Autophagy in Cell Cycle Control and Its Implications in Cancer
Andrade-Tomaz, M., de Souza, I., Rocha, C. R. R., & Gomes, L. R. (2020) · Cells · doi:10.3390/cells9092140 · Cited by 84
Role of Ubiquitin–Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance
Sahoo, S., Padhy, A. A., Kumari, V., & Mishra, P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02897-1 · Cited by 82
Schwarz, L., Goldbaum, O., Bergmann, M., Probst‐Cousin, S., & Richter‐Landsberg, C. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9733-5 · Cited by 84
Review: Autophagy and neurodegeneration: survival at a cost?
Cherra, S. J., Dagda, R. K., & Chu, C. T. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01062.x · Cited by 81
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease
Macchi, B., Paola, R. D., Marino‐Merlo, F., Felice, M. R., Cuzzocrea, S., & Mastino, A. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150225124928 · Cited by 80
Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins
Callizot, N., Combes, M., Henriques, A., & Poindron, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215277 · Cited by 81
α-synuclein impairs autophagosome maturation through abnormal actin stabilization
Sarkar, S., Olsen, A. L., Sygnecka, K., Lohr, K. M., & Feany, M. Β. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009359 · Cited by 82
Rothaug, M., Stroobants, S., Schweizer, M., Peters, J., Zunke, F., Allerding, M., D’Hooge, R., Säftig, P., & Blanz, J. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0182-y · Cited by 82
Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease
Sala, G., Marinig, D., Arosio, A., & Ferrarese, C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00157 · Cited by 82
Chaperone mediated autophagy degrades TDP-43 protein and is affected by TDP-43 aggregation
Ormeño, F., Hormazabal, J., Moreno, J., Riquelme, F., Rios, J., Criollo, A., Albornoz, A., Alfaro, I. E., & Budini, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00019 · Cited by 80
Interplay between Sumoylation and Phosphorylation for Protection against α-Synuclein Inclusions
Shahpasandzadeh, H., Popova, B., Kleinknecht, A., Fraser, P. E., Outeiro, T. F., & Braus, G. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559237 · Cited by 81
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Teil, M., Arotçarena, M.-L., Faggiani, E., Laferrière, F., Bézard, E., & Dehay, B. (2020) · Biomolecules · doi:10.3390/biom10030391 · Cited by 80
Chaperone-mediated autophagy: Dice's 'wild' idea about lysosomal selectivity
Cuervo, A. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3150 · Cited by 94
The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
Rideout, H. J., & Stefanis, L. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1073-5 · Cited by 82
Self-citationEvidence of Native α-Synuclein Conformers in the Human Brain
Gould, N. S., Mor, D. E., Lightfoot, R. T., Malkus, K. A., Giasson, B. I., & Ischiropoulos, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.538249 · Cited by 80
Silencing DJ‐1 reveals its contribution in paraquat‐induced autophagy
González‐Polo, R. A., Niso‐Santano, M., Morán, J. M., Ortiz‐Ortiz, M. A., Pedro, J. M. B., Soler, G., & Fuentes, J. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06020.x · Cited by 76
Suntharalingam, A., Abisambra, J. F., O’Leary, J. C., Koren, J., Zhang, B., Joe, M. K., Blair, L. J., Hill, S. E., Jinwal, U. K., Cockman, M. E., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384800 · Cited by 76
Charcot–Marie–Tooth disease and intracellular traffic
Bucci, C., Bakke, O., & Progida, C. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.003 · Cited by 78
Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
Bobela, W., Aebischer, P., & Schneider, B. L. (2015) · Biomolecules · doi:10.3390/biom5042675 · Cited by 75
Metadata
- Authors
- Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L.
- Affiliations
- Biomedical Research Foundation of the Academy of Athens (GR)
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Stefanis, Leonidas
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 283
- Issue
- 35
- Pages
- 23542-23556
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2527094
- OpenAlex
- W2026175550
- Cited by
- 683
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 43 · 2023: 44 · 2022: 36 · 2021: 48 · 2020: 56 · 2019: 40 · 2018: 34 · 2017: 32 · 2016: 30 · 2015: 33 · 2014: 39 · 2013: 39 · 2012: 41
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R21NS055693)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- alpha-synuclein, chaperone-mediated autophagy, macroautophagy, Parkinson's disease, LAMP2A, lysosomal degradation, post-transcriptional regulation, PC12 cells, SH-SY5Y cells, cortical neurons, midbrain neurons, protein turnover
- MeSH terms
- Animals, Autophagy, Cerebral Cortex, Humans, Mesencephalon, Neurons, Parkinson Disease, PC12 Cells, Rats, Wistar, Molecular Chaperones, Mice, Rats, alpha-Synuclein, Lysosomal Membrane Proteins, Lysosomal-Associated Membrane Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
